Navigation Links
European Commission Grants Orphan Medicinal Product Designation for Emmaus Medical's Sickle Cell Treatment
Date:7/17/2012

mall blood vessels.  The condition causes debilitating pain crises and organ damages that can lead to death at an early age.  An estimated 200,000 people in the United States and the Europe Union, and four to five million people worldwide, primarily in Latin America and Africa, are afflicted.  Currently, there is no universal cure for sickle cell disease. 

About Emmaus Medical, Inc.
Founded in 2000, Emmaus Medical, Inc. is a specialty pharmaceutical company, and subsidiary of Emmaus Life Sciences, Inc., dedicated to the discovery, development and commercialization of innovative and cost-effective treatments and therapies for rare diseases. The company is completing its Phase III clinical trial for a treatment for sickle cell disease and has entered into a collaborative agreement for the research, development and commercialization of regenerative medicine technology products. For more information, please visit www.emmausmedical.com and www.nutrestore.com.

Forward-Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. These statements are often, but not always, made through the use of words or phrases such as "anticipates," "expects," "plans," "believes," "intends," and similar words or phrases. These forward-looking statements include, without limitation, statements regarding completion of the Phase III clinical trial in 2013, the potential for the L-glutamine treatment for sickle cell disease, the timing, progress and anticipated results of the clinical development of the L-glutamine treatment for sickle cell disease, Emmaus' ability to fund the development of the L-glutamine treatment to completion, as well as Emmaus' plans and objectives. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-l
'/>"/>

SOURCE Emmaus Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
2. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
3. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
4. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
5. Mylan Launches Generic Lipitor® in Five European Countries
6. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
7. Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
8. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
9. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
10. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
11. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Ill. , May 21, 2013 Reaching ... approval process, the National Association of Boards of Pharmacy ... operate the .PHARMACY domain suffix has passed the Internet ... NABP intends to launch the .PHARMACY gTLD by the ... available to legitimate online pharmacies and related entities that ...
(Date:5/21/2013)... May 21, 2013 Concord Medical Services Holdings ... CCM ), a leading specialty hospital management solution provider ... diagnostic imaging centers in China and the parent of ... for the first quarter ended March 31, 2013 [1] ... Total net revenue, which consists of net revenues generated ...
(Date:5/21/2013)... , May 21, 2013  NxStage Medical, Inc. (Nasdaq: ... dialysis products, today announced that it has entered into ... and in-center products to DaVita, the kidney care division ... ) For the use of products ... , NxStage has executed a second amended and ...
Breaking Medicine Technology:NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 2NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 3Concord Medical Reports First Quarter 2013 Financial Results 2Concord Medical Reports First Quarter 2013 Financial Results 3Concord Medical Reports First Quarter 2013 Financial Results 4Concord Medical Reports First Quarter 2013 Financial Results 5Concord Medical Reports First Quarter 2013 Financial Results 6Concord Medical Reports First Quarter 2013 Financial Results 7Concord Medical Reports First Quarter 2013 Financial Results 8Concord Medical Reports First Quarter 2013 Financial Results 9Concord Medical Reports First Quarter 2013 Financial Results 10Concord Medical Reports First Quarter 2013 Financial Results 11Concord Medical Reports First Quarter 2013 Financial Results 12Concord Medical Reports First Quarter 2013 Financial Results 13NxStage Announces New Agreements with DaVita 2
... (Nasdaq: REGN ) will webcast its presentation at the ... Tuesday, May 10, 2011 at 9:20 a.m. Pacific Time (12:20 ... Company,s web site, www.regeneron.com , on the Investor Relations ... after the live webcast through May 27, 2011.   ...
... Vertical Health Solutions, Inc. (OTCQB: VHSLD) announced that it ... that the Financial Industry Regulatory Authority has approved a ...  The stock ticker change has gone into effect for ... note that the "D" will be removed from the ...
Cached Medicine Technology:Vertical Health Solutions to Begin Doing Business as OnPoint Medical Diagnostics and Announces Completion of Symbol Change 2
(Date:5/21/2013)... 2013 The University of Colorado’s Anschutz ... HEALTHY DINING to help Coloradans make healthier choices when ... program is called HEALTHY DINING IN COLORADO. More ... participating in Colorado. Restaurants will offer a selection of ... lean protein, vegetables, fruits, whole grains and unsaturated fats. ...
(Date:5/21/2013)... Springs, CO (PRWEB) May 22, 2013 ... plan for better nutrition--from farmers' markets filled with whole ... consumers make the most of the season the nutrition ... a healthier lifestyle not to miss. , 1. Eating ... weather that invites shoppers to linger and explore, spring ...
(Date:5/21/2013)... 2013 Swimsuit season is almost here. The ... products has begun with a 35% discount. , Cellulite forms ... women get the dreaded cellulite even if they are in ... where they have been stored as toxic lymph and smashed ... fixes, a specific program that works to dissolve the toxins ...
(Date:5/21/2013)... Bradley, Illinois (PRWEB) May 21, 2013 ... living community], a BMA affordable assisted living community, is hosting ... Don'ts of Arthritis at 2 p.m. on Tuesday, May 28. ... in Dwight, Illinois, serves older adults of all incomes, including ... independence. , The Arthritis program is open to the public. ...
(Date:5/21/2013)... Feed additives have now become an essential part ... of the feed additives are used in micro quantities ... There are variety of feed additives available that are ... type of animal and feed. Nutritional feed additives are ... to the animal in order to gain lean meat ...
Breaking Medicine News(10 mins):Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 3Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2Health News:Heritage Woods of Dwight Affordable Assisted Living to Host Informational Program on the Do's and Don'ts of Arthritis 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4
... seem to be obstinate, as scientists have discovered, as ... result, they are extremely// difficult to annihilate. In fact ... cells, warn researchers from the University of California, Los ... tendency of stem cells that get radiation resistant and ...
... Tuesday said the government was keen to interact with leaders ... India.// ,According to him, a sense of ... year had led to the growth of the disease in ... number of discussions with minority leaders of Uttar Pradesh and ...
... is made possible by Colonoscopy. More patients are willing to ... in// the bud at the very onset. ... at Yale University, found that there is a significant rise ... colon cancer in people .This has helped early treatment possible. ...
... a hospital here after he complained of high blood ... was on way to Delhi airport to take a ... of ill health. He was taken to the Escorts ... under observation," said Jugal Sharma, a spokesperson for the ...
... Chan and her colleagues from Dana-Farber Cancer Institute suggests// ... for scientists working on new therapies for colon cancer. ... women’s health, the investigators found that postmenopausal women with ... dying of the disease if they had been taking ...
... Setting an example, all members of the Andhra Pradesh legislative ... ,Chief Minister Y. S. Rajasekhara Reddy, Speaker K. R. Suresh ... parties Monday underwent HIV tests at a medical camp held ... minister said all 295 members of state assembly should undergo ...
Cached Medicine News:Health News:Colonoscopy Aids Early Detection of Colon Cancer 2Health News:Estrogen Study Provides New Hope For Colon Cancer Treatment 2
... These Low Contrast Flip charts contain 5 ... Numbers on each page. Optotype size is 9.5M. ... 1.25%. These flip charts can be used at ... for the same test. Each offers a ...
The PowerLab/4ST is a high-performance recording unit with built-in amplifiers and is suitable for physiology teaching. It has been designed to cover the broad experimental requirements in life scien...
... high-performance data acquisition system suitable for a ... that require up to 8 input channels. ... speeds of up to 200 000 samples ... compatible with instruments, signal conditioners and transducers ...
... In 1992 BioControl introduced the Biomuse, ... and analyzes any type of human bioelectric ... other processor based devices. This unit is ... for a range of applications. BioControl has ...
Medicine Products: